These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9249785)

  • 1. Purification and localization of a 25-kD porcine renal puromycin aminonucleoside-binding protein.
    Kodama T; Wakui H; Komatsuda A; Imai H; Miura AB; Tashima Y
    Nephrol Dial Transplant; 1997 Jul; 12(7):1453-60. PubMed ID: 9249785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal alpha-actinin-4: purification and puromycin aminonucleoside-binding property.
    Goto H; Wakui H; Komatsuda A; Ohtani H; Imai H; Sawada K; Kobayashi R
    Nephron Exp Nephrol; 2003 Jan; 93(1):e27-35. PubMed ID: 12411747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and immunohistochemical localization of a 17-kD porcine renal puromycin aminonucleoside binding protein.
    Wakui H; Komatsuda A; Kodama T; Mamiya S; Miura AB
    Ren Physiol Biochem; 1995; 18(3):109-17. PubMed ID: 7542791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular mesangium. Analysis of the increased activity observed in experimental acute aminonucleoside nephrosis in the rat.
    Grond J; Elema JD
    Lab Invest; 1981 Nov; 45(5):400-9. PubMed ID: 7300251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of heparanase in puromycin aminonucleoside nephrosis.
    Levidiotis V; Kanellis J; Ierino FL; Power DA
    Kidney Int; 2001 Oct; 60(4):1287-96. PubMed ID: 11576343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
    Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
    Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis.
    Huang S; Schaefer RM; Reisch S; Paczek L; Schaefer L; Teschner M; Sebekova K; Heidland A
    Kidney Blood Press Res; 1999; 22(3):121-7. PubMed ID: 10394110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR; Karnovsky MJ
    J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.
    Jones CL; Buch S; Post M; McCulloch L; Liu E; Eddy AA
    Am J Pathol; 1992 Dec; 141(6):1381-96. PubMed ID: 1281619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo detection of intrinsic reactive oxygen species using acyl-protected hydroxylamine in puromycin nephrosis.
    Ueda A; Hirayama A; Nagase S; Inoue M; Oteki T; Aoyama M; Yokoyama H
    Free Radic Res; 2007 Jul; 41(7):823-8. PubMed ID: 17577743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in glomerular heparan sulfate in puromycin aminonucleoside nephrosis.
    Groggel GC; Hovingh P; Border WA; Linker A
    Am J Pathol; 1987 Sep; 128(3):521-7. PubMed ID: 2443012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the aminonucleoside of puromycin on glomerular epithelial cells in vitro.
    Fishman JA; Karnovsky MJ
    Am J Pathol; 1985 Mar; 118(3):398-407. PubMed ID: 3976843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
    Ebihara I; Nakamura T; Tomino Y; Koide H
    Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and partial purification of microsomal NAD(P)H:quinone oxidoreductases.
    Jaiswal AK
    Arch Biochem Biophys; 2000 Mar; 375(1):62-8. PubMed ID: 10683249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.
    Dong N; Meng L; Xue R; Yu M; Zhao Z; Liu X
    Int Urol Nephrol; 2017 Aug; 49(8):1489-1506. PubMed ID: 28528353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside.
    Vega-Warner V; Ransom RF; Vincent AM; Brosius FC; Smoyer WE
    Kidney Int; 2004 Nov; 66(5):1881-9. PubMed ID: 15496159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
    Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ
    Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
    Ricardo SD; Bertram JF; Ryan GB
    Exp Nephrol; 1995; 3(5):270-9. PubMed ID: 7583048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.